<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>All in One Longevity Supplement on Longetivities</title><link>https://longetivities.com/tags/all-in-one-longevity-supplement/</link><description>Recent content in All in One Longevity Supplement on Longetivities</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 16 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://longetivities.com/tags/all-in-one-longevity-supplement/feed.xml" rel="self" type="application/rss+xml"/><item><title>Blueprint vs NOVOS Core: Anti-Aging, Biological Age, And Cellular Health Comparison</title><link>https://longetivities.com/blog/blueprint-vs-novos-core-anti-aging-biological-age-and-cellular-health-comparison/</link><pubDate>Tue, 27 Jan 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/blueprint-vs-novos-core-anti-aging-biological-age-and-cellular-health-comparison/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Head-to-Head Protocol Comparisons&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/compare-longevity-protocols-practical-framework-for-low-risk-biohacking/"&gt;Compare Longevity Protocols: Practical Framework For Low-Risk Biohacking&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;The anti aging supplements market hit $4.6 billion globally in 2023 and continues expanding at 8.5% annually. By 2050, over 1.5 billion people worldwide will be aged 60 or older, driving unprecedented interest in longevity science and biological age reversal.&lt;/p&gt;
&lt;p&gt;Two products dominate conversations in this space: Bryan Johnson’s Blueprint Longevity Mix and NOVOS Core from NOVOS Labs. Both promise to address cellular aging through research-backed formulations, but they take fundamentally different approaches to the aging process.&lt;/p&gt;</description></item></channel></rss>